Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (271-280 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|January 17, 2018
CNS cancer: TTFields improve survivalDavid Killock
Nature Reviews. Clinical Oncology|April 3, 2020
Selumetinib benefits children with inoperable plexiform neurofibromasDavid Killock
Nature Reviews. Clinical Oncology|September 24, 2020
TMB - a histology-agnostic predictor of the efficacy of ICIs?David Killock
Nature Reviews. Clinical Oncology|December 22, 2020
Sequential CRT prior to surgery for rectal cancerDavid Killock
Nature Reviews. Clinical Oncology|December 22, 2020
Pembrolizumab can delay progression of TNBCDavid Killock
Nature Reviews. Clinical Oncology|November 1, 2023
From the ESMO Congress 2023David Killock
Nature Reviews. Clinical Oncology|November 17, 2021
Early ICI uptake on PET predicts responseDavid Killock
Nature Reviews. Clinical Oncology|May 16, 2019
Anti-BCMA CAR T cells for MMDavid Killock
Nature Reviews. Clinical Oncology|April 1, 2022
CAR T cells show promise in the frontline for high-risk LBCLDavid Killock
Nature Reviews. Clinical Oncology|October 13, 2019
CDK4/6 inhibitors prolong OSDavid Killock
Pageof 31

Showing results (271-280 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|January 17, 2018
CNS cancer: TTFields improve survivalDavid Killock
Nature Reviews. Clinical Oncology|April 3, 2020
Selumetinib benefits children with inoperable plexiform neurofibromasDavid Killock
Nature Reviews. Clinical Oncology|September 24, 2020
TMB - a histology-agnostic predictor of the efficacy of ICIs?David Killock
Nature Reviews. Clinical Oncology|December 22, 2020
Sequential CRT prior to surgery for rectal cancerDavid Killock
Nature Reviews. Clinical Oncology|December 22, 2020
Pembrolizumab can delay progression of TNBCDavid Killock
Nature Reviews. Clinical Oncology|November 1, 2023
From the ESMO Congress 2023David Killock
Nature Reviews. Clinical Oncology|November 17, 2021
Early ICI uptake on PET predicts responseDavid Killock
Nature Reviews. Clinical Oncology|May 16, 2019
Anti-BCMA CAR T cells for MMDavid Killock
Nature Reviews. Clinical Oncology|April 1, 2022
CAR T cells show promise in the frontline for high-risk LBCLDavid Killock
Nature Reviews. Clinical Oncology|October 13, 2019
CDK4/6 inhibitors prolong OSDavid Killock
Pageof 31